Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the agency's Division of Dockets Management.
Submit written requests for copies of summaries of safety and effectiveness to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Thinh Nguyen, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2186 ext. 152.End Further Info End Preamble Start Supplemental Information
In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to discontinue individual publication of PMA approvals and denials in the Federal Register. Instead, the agency now posts this information on the Internet on FDA's home page at http://www.fda.gov. FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.
In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30 day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30 day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30 day period will begin when the applicant is notified by FDA in writing of its decision.
The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from October 1, 2005 through December 31, 2005. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.
Table 1.—List of Safety and Effectiveness Summaries for Approved PMAs Made Available From October 1, 2005 through December 31, 2005
|PMA No./Docket No.||Applicant||Trade Name||Approval Date|
|P960040(S28)/2005M-0435||Guidant CRM Corp.||VENTAK PRIZM AVT AICD SYSTEM||March 27, 2003|
|P020045/2005M-0475||CryoCath Technologies, Inc.||7F FREEZOR CARDIAC CRYOBLATION CATHETER & CCT.2 CRYOCONSOLE SYSTEM||April 17, 2003|
|P040003/2005M-0473||InSightec—North America||EXABLATE 2000 SYSTEM||October 22, 2004|
|P030056/2005M-0478||Bayer Healthcare, LLC||ADVIA CENTAUR HCV READY PACK REAGENTS, ADVIA CENTAUR HCV QUALITY CONTROL MATERIALS||December 22, 2004|
|P980022(S11)/2005M-0454||Medtronic MiniMed||GUARDIAN RT CONTINUOUS GLUCOSE MONITORING SYSTEM||July 18, 2005|
|P020016/2005M-0399||Walter Lorenz Surgical, Inc.||TOTAL TEMPOMANDIBULAR JOINT REPLACEMENT SYSTEM||September 21, 2005|
|P040047/2005M-0477||Bioform Medical, Inc.||COAPTITE||November 10, 2005|
|P040042/2005M-0476||Irvine Biomedical, Inc.||THERAPY DUAL 8 CARDIAC ABLATION SYSTEM||November 18, 2005|
|P030054(S10)/2005M-0492||St. Jude Medical CRMD||EPIC & ATLAS + HF CRT-D SYSTEMS||November 18, 2005|
|P040013/2005M-0474||Biomimetic Therapeutics, Inc.||GEM 21S (GROWTH-FACTOR ENHANCED MATRIX)||November 18, 2005|
|Start Printed Page 13856|
|P040045/2005M-0504||Vistakon, Division of Johnson & Johnson Vision Care, Inc.||VISTAKON (SENOFILCON A) CONTACT LENS, CLEAR AND VISIBILITY TINTED WITH UV BLOCKER||December 20, 2005|
II. Electronic Access
Persons with access to the Internet may obtain the documents at http://www.fda.gov/cdrh/pmapage.html.Start Signature
Dated: March 7, 2006.
Linda S. Kahan,
Deputy Director, Center for Devices and Radiological Health.
[FR Doc. E6-3850 Filed 3-16-06; 8:45 am]
BILLING CODE 4160-01-S